Cargando…

Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease

Background: Deceased muscle mass combined with increased visceral fat mass is reportedly linked to a higher risk of worsening the hepatic conditions of non-alcoholic fatty liver disease (NAFLD). Objective: The aim of this study was conducted in a retrospective manner to investigate whether longitudi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shida, Takashi, Oshida, Natsumi, Oh, Sechang, Okada, Kosuke, Shoda, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489648/
https://www.ncbi.nlm.nih.gov/pubmed/31114278
http://dx.doi.org/10.2147/DMSO.S185705
_version_ 1783414859145150464
author Shida, Takashi
Oshida, Natsumi
Oh, Sechang
Okada, Kosuke
Shoda, Junichi
author_facet Shida, Takashi
Oshida, Natsumi
Oh, Sechang
Okada, Kosuke
Shoda, Junichi
author_sort Shida, Takashi
collection PubMed
description Background: Deceased muscle mass combined with increased visceral fat mass is reportedly linked to a higher risk of worsening the hepatic conditions of non-alcoholic fatty liver disease (NAFLD). Objective: The aim of this study was conducted in a retrospective manner to investigate whether longitudinal changes in skeletal muscle mass to visceral fat area ratio (SV ratio), an index of sarcopenic obesity, are influential on the hepatic conditions and pathophysiology of NAFLD during the clinical course. Design: The association of SV ratio with hepatic conditions and pathophysiology was evaluated longitudinally for 2–5.5 years (median 4.1 years) in 92 patients with NAFLD (36 men and 56 women; 17–78 years). The subjects were divided into three groups according to the change in their SV ratio: improved, stable, or worsened, and the changes in parameters associated with NAFLD were compared among the groups. Results: In the group with a worsened SV ratio, visceral fat area increased (122±30–138±30 cm(2); mean ± SD), whereas total muscle mass decreased (26.5±6.1–25.9±5.9 kg), which was especially noticeable in the lower extremities (14.8±3.3–14.3±3.1 kg). In accordance with the change of body composition, transient elastography showed higher levels of liver stiffness (7.7±5.4–9.0±6.0 kPa) and fat accumulation (265±43–293±48 dB/m). There were also higher levels of fasting plasma glucose (115±29–126±40 mg/dL) and HbA1c (6.0±1.1–6.3±1.0%). In contrast, deterioration in these parameters did not occur in the groups with improved or stable SV ratios. Conclusion: Collectively, a progressive reduction in skeletal muscle mass accompanied by an increase in visceral fat mass during the clinical course of NAFLD is associated with a worsening of the hepatic conditions, fat accumulation and progression of fibrosis.
format Online
Article
Text
id pubmed-6489648
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-64896482019-05-21 Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease Shida, Takashi Oshida, Natsumi Oh, Sechang Okada, Kosuke Shoda, Junichi Diabetes Metab Syndr Obes Original Research Background: Deceased muscle mass combined with increased visceral fat mass is reportedly linked to a higher risk of worsening the hepatic conditions of non-alcoholic fatty liver disease (NAFLD). Objective: The aim of this study was conducted in a retrospective manner to investigate whether longitudinal changes in skeletal muscle mass to visceral fat area ratio (SV ratio), an index of sarcopenic obesity, are influential on the hepatic conditions and pathophysiology of NAFLD during the clinical course. Design: The association of SV ratio with hepatic conditions and pathophysiology was evaluated longitudinally for 2–5.5 years (median 4.1 years) in 92 patients with NAFLD (36 men and 56 women; 17–78 years). The subjects were divided into three groups according to the change in their SV ratio: improved, stable, or worsened, and the changes in parameters associated with NAFLD were compared among the groups. Results: In the group with a worsened SV ratio, visceral fat area increased (122±30–138±30 cm(2); mean ± SD), whereas total muscle mass decreased (26.5±6.1–25.9±5.9 kg), which was especially noticeable in the lower extremities (14.8±3.3–14.3±3.1 kg). In accordance with the change of body composition, transient elastography showed higher levels of liver stiffness (7.7±5.4–9.0±6.0 kPa) and fat accumulation (265±43–293±48 dB/m). There were also higher levels of fasting plasma glucose (115±29–126±40 mg/dL) and HbA1c (6.0±1.1–6.3±1.0%). In contrast, deterioration in these parameters did not occur in the groups with improved or stable SV ratios. Conclusion: Collectively, a progressive reduction in skeletal muscle mass accompanied by an increase in visceral fat mass during the clinical course of NAFLD is associated with a worsening of the hepatic conditions, fat accumulation and progression of fibrosis. Dove 2019-04-15 /pmc/articles/PMC6489648/ /pubmed/31114278 http://dx.doi.org/10.2147/DMSO.S185705 Text en © 2019 Shida et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Shida, Takashi
Oshida, Natsumi
Oh, Sechang
Okada, Kosuke
Shoda, Junichi
Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
title Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
title_full Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
title_fullStr Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
title_full_unstemmed Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
title_short Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
title_sort progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489648/
https://www.ncbi.nlm.nih.gov/pubmed/31114278
http://dx.doi.org/10.2147/DMSO.S185705
work_keys_str_mv AT shidatakashi progressivereductioninskeletalmusclemasstovisceralfatarearatioisassociatedwithaworseningofthehepaticconditionsofnonalcoholicfattyliverdisease
AT oshidanatsumi progressivereductioninskeletalmusclemasstovisceralfatarearatioisassociatedwithaworseningofthehepaticconditionsofnonalcoholicfattyliverdisease
AT ohsechang progressivereductioninskeletalmusclemasstovisceralfatarearatioisassociatedwithaworseningofthehepaticconditionsofnonalcoholicfattyliverdisease
AT okadakosuke progressivereductioninskeletalmusclemasstovisceralfatarearatioisassociatedwithaworseningofthehepaticconditionsofnonalcoholicfattyliverdisease
AT shodajunichi progressivereductioninskeletalmusclemasstovisceralfatarearatioisassociatedwithaworseningofthehepaticconditionsofnonalcoholicfattyliverdisease